Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxceed in Rheumatoid Arthritis
NCT00055133Phase 2Completed
- Sponsor
- Angiotech Pharmaceuticals
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Paxceed in rheumatoid arthritis (RA), sponsored by Angiotech Pharmaceuticals. Started Sep 2002; status: completed.
02
Drugs
Paxceed
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00055133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055133.